Chang Y C, Patz E F, Goodman P C
Department of Radiology, Duke University Medical Center, Durham, NC 27710, USA.
AJR Am J Roentgenol. 1996 May;166(5):1049-51. doi: 10.2214/ajr.166.5.8615239.
The objective of this study was to evaluate the incidence and significance of pneumothorax after small-bore chest tube placement for symptomatic malignant pleural effusions.
Over a 2-year period, 90 patients with a known primary malignant tumor and symptomatic pleural effusion were referred to the radiology service at Duke University Medical Center. All patients underwent placement of a small-bore chest tube with fluid drainage in preparation for intrapleural sclerotherapy. Two of these patients were excluded because of coexisting empyema (n=1) and thoracentesis (n=1). The remaining 88 patients (30 men and 58 women; 26-86 years old [mean, 60 years old], who had 90 chest tubes placed, formed our study group. The incidence, duration, and clinical significance of their pneumothoraces and the amount of pleural effusion drained were recorded.
Among the 88 patients with 90 chest tubes, 27 patients with 28 chest tubes (31%) were found to have pneumothorax after the procedure. For 23 patients with 24 chest tubes, pneumothorax was evident on chest radiographs taken immediately after tube insertion and fluid drainage. Four patients with four chest tubes were found to have pneumothorax on chest radiographs taken the next day. No significant difference in the amount of fluid drained during the procedure was noted for patients with or without pneumothorax (831 ml versus 853 ml). No relationship between the size of each pneumothorax and the size of each drainage catheter was seen. The duration of pneumothorax ranged from 2 hr to 18 days (average, 3.5 days). Resolution of pneumothorax was seen in 22 (79%) of 28 cases; the remaining six cases of pneumothorax (21%) were stable, and the patients showed eventual fluid reaccumulation after chest tube removal and no sclerotherapy. No patient developed tension pneumothorax, respiratory distress, or other complications.
Pneumothorax should be recognized as a common finding after chest tube placement and immediate fluid drainage for malignant pleural effusions. We suggest that this finding is related to rapid removal of fluid from a relatively stiff, noncompliant lung. Patients whose lungs do not fully re-expand in several days will probably not benefit from sclerotherapy. Their tubes may be removed without risk of an enlarging tension pneumothorax.
本研究的目的是评估在为有症状的恶性胸腔积液放置细口径胸腔引流管后气胸的发生率及意义。
在两年期间,90例已知原发性恶性肿瘤并有症状性胸腔积液的患者被转诊至杜克大学医学中心放射科。所有患者均接受细口径胸腔引流管置入以引流积液,为胸膜腔内注入硬化剂做准备。其中2例患者因合并脓胸(n = 1)和胸腔穿刺(n = 1)被排除。其余88例患者(30例男性和58例女性;年龄26 - 86岁[平均60岁])共置入90根胸腔引流管,组成我们的研究组。记录他们气胸的发生率、持续时间、临床意义以及引流的胸腔积液量。
在88例置入90根胸腔引流管的患者中,27例患者的28根引流管(31%)在置管后被发现存在气胸。对于23例患者的24根引流管,在置管及引流积液后立即拍摄的胸部X线片上气胸明显。4例患者的4根引流管在次日拍摄的胸部X线片上被发现存在气胸。有气胸和无气胸患者在操作过程中引流的积液量无显著差异(831 ml对853 ml)。未观察到气胸大小与各引流导管大小之间的关系。气胸持续时间为2小时至18天(平均3.5天)。28例中的22例(79%)气胸得到缓解;其余6例气胸(21%)情况稳定,患者在拔除胸腔引流管且未注入硬化剂后最终出现积液再次积聚。无患者发生张力性气胸、呼吸窘迫或其他并发症。
气胸应被视为为恶性胸腔积液放置胸腔引流管并立即引流积液后的常见情况。我们认为这一发现与相对僵硬、顺应性差的肺内液体快速排出有关。肺部在数天内未完全复张的患者可能无法从注入硬化剂中获益。可以拔除他们的引流管,而无张力性气胸扩大的风险。